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Introduction
Intracranial hemorrhage after the rupture of cerebral 
aneurysms in pediatric patients is rare and bears less 
than 2% of the overall mortality.1
Cardiovascular complications often occur in the 
early phase after spontaneous aneurysmatic rupture.2 
Even though extracorporeal life support (ECLS) is well-
established in patients suffering from acute catechola-
mine refractory myocardial failure, it is traditionally 
considered contraindicated in pediatric patients with 
extended intracranial hemorrhage.3
We present the case of a nine-year-old female patient 
who suffered a spontaneous intracranial hemorrhage 
after aneurysmatic rupture, with the necessity of veno-
arterial extracorporeal membrane oxygenation (V-A 
ECMO) support to treat sepsis-induced cardiac failure.
Informed consent was obtained from the parents 
for publication of this report, including the accompa-
nying images.
Case History
This previously healthy nine-year-old girl with sponta-
neous out-of-hospital collapse, a Glasgow Coma Score 
of 3 and a fixed and dilated right pupil was intubated 
for airway protection at the scene. Cranial computed 
tomography revealed an extended right-sided fronto-
temporal and subarachnoid hemorrhage coterminous 
to a middle cerebral artery (MCA)- communicating 
giant aneurysm (Figure 1). The hematoma was evacu-
ated and the aneurysm clipped by the neurosurgeon, 
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but immediate postoperative angiography showed a 
territorial stroke due to loss of MCA perfusion distal to 
the clips. The patient was admitted to the pediatric 
intensive care unit for further monitoring and treat-
ment. She had an otherwise uncomplicated early post-
operative course under standard neuroprotective 
therapy, consisting of a cerebral perfusion pressure 
above 60 mmHg, strict normothermia, a partial pres-
sure of arterial carbon dioxide (PaCO2) of 33 to 37 
mmHg and osmotherapy with hyperosmolar sodium 
chloride. On day 4 after the craniotomy, she became 
septic, with a full systemic inflammatory response syn-
drome score, a maximum procalcitonin level of 21.4 
ng/ml and a growth of Staphylococcus aureus in the 
blood culture treated with vancomycin. Sepsis-induced 
myocardial dysfunction with arrhythmias and poor 
biventricular contractility led to a catecholamine 
refractory shock. Due to rapid deterioration and inad-
equate cerebral perfusion pressure (CPP), the decision 
for the initiation of V-A ECMO support was made. 
Central cannulation ensued; a 14 Fr arterial cannula 
was placed into the ascending aorta and a 24 Fr venous 
cannula into the right atrium. The central site for can-
nulation was chosen to provide the best flow to the 
injured head without impairing the cerebral venous 
drainage. The ECMO set-up consisted of a 3/8” hepa-
rin-coated circuit and a Quadrox Ped BE 3000 
oxygenator with a Rotaflow centrifugal pump (Maquet, 
Hirrlingen, Germany). The system’s total priming vol-
ume was 500 ml; no heparin was given to the patient or 
into the circuit at ECMO initiation. Further anticoagu-
lation was maintained using a heparin infusion, titrated 
to an activated partial thromboplastin time (aPTT) of 
45-55 seconds. The median aPTT was 45 (34-55) 
seconds with a mean heparin dose of 13 units per kg 
bodyweight per hour for the ECMO run. As per rou-
tine, the central venous saturation (CvO2) was main-
tained above 60%, the regional cerebral oxygen 
saturation (rSO2) measured by near-infrared spectros-
copy (NIRS) above 60% and the partial pressure of 
arterial oxygen (PaO2) was kept above 95 mmHg. The 
arrhythmias were treated with an amiodarone infusion 
and overridden with atrio-ventricular sequential 
pacing. With an initial V-A ECMO blood flow rate 
of2.0 L/min (Cardiac Index 1.88 L/min/m2), the 
patient’s CPP, CvO2, rSO2, PaO2 and PaCO2 remained 
in the targeted ranges. Subsequently, the serum lactate 
value dropped from 101 to 28 mg/dL within the first 24 
hours. After significant improvement of cardiac 
function, the blood flow rate was constantly weaned to 
a minimum of 0.7 L/min (Cardiac Index 0.66 L/min/
m2) over 4 hours without increasing the heparin dose 
and the cannulas were removed 5 days after the initia-
tion of V-A ECMO support. During the ECMO run, 
the maximum values for D-dimer and free hemoglobin 
were 22.4 mg/L and 219 mg/L, respectively. Four weeks 
after admission, the girl was transferred to the 
pediatric rehabilitation center. Three months after the 
collapse, she had a very satisfactory neurologic recov-
ery with normal cognitive function, but moderate left 
proximal hemiparesis without cranial nerve involve-
ment. She is able to walk without any support and 
successfully attends her former school class.
Discussion
In adults, ECMO support in patients with an intracra-
nial hemorrhage is controversial and relatively contra-
indicated as the required anticoagulation for ECMO 
puts the patient at risk for progression of the hemor-
rhage and potentially aggravates outcome. However, 
successful ECMO treatment for respiratory failure in 
adult patients with traumatic brain injury and intracra-
nial hemorrhage after spontaneous aneurysmatic rup-
ture has been reported.4–7 Most of these runs were 
performed in the veno-venous mode and both with and 
without systemic anticoagulation. To the best of our 
knowledge, this is the first report on the use of V-A 
ECMO for the treatment of circulatory failure in a (pedi-
atric) patient early after craniotomy for intracranial 
aneurysmatic hemorrhage.
Figure 1. Cranial computer tomography scan upon admission 
to our hospital: extended right-sided fronto-temporal 
hemorrhage co-terminous to a middle cerebral artery-
communicating giant aneurysm.
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In this case, systemic anticoagulation during ECMO 
was performed using a heparin infusion. To minimize 
the risk of further intracranial bleeding, a low aPTT 
target range of 45-55 seconds was chosen. As confirmed 
by a median aPTT of 45 seconds during the V-A ECMO 
run, significantly less heparin effect was achieved than 
traditionally reported or recommended.8,9 Comparable 
to patients with bleeding on ECMO after pediatric 
heart surgery, a reduction in anticoagulation was not 
associated with clotting complications.10 Furthermore, 
ECMO facilitated the maintenance of the standard 
brain protective therapy, with the additional benefit of 
a significant reduction in inotropic support for poor 
cardiac function and concomitant arrhythmias. In 
severe sepsis, a reduced cardiac output due to poor con-
tractility is commonly seen in children, whereas adults 
usually present it earlier in a hyperdynamic state.11 This 
may explain the higher recovery rate in pediatric patients 
requiring ECMO treatment for sepsis, especially with 
central cannulation.12–14
In summary, we present the case of a pediatric patient 
with extended intracranial hemorrhage who was suc-
cessfully treated with V-A ECMO for post-operative 
sepsis-induced cardiac failure. Central cannulation to 
provide good blood flow to the injured brain’s penum-
bra without impairing the cerebral venous drainage and 
a modified anticoagulation management to minimize 
the risk of significant intracranial re-bleeding allowed 
an uncomplicated ECMO course with good neurologi-
cal recovery of the patient.
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